Keros Therapeutics, Inc. (KROS)
11.03
-0.20
(-1.78%)
USD |
NASDAQ |
Aug 28, 16:00
11.05
+0.02
(+0.18%)
Pre-Market: 20:00
Keros Therapeutics Free Cash Flow : -48.49M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -48.49M |
| March 31, 2026 | -58.25M |
| December 31, 2025 | 105.95M |
| September 30, 2025 | 87.08M |
| June 30, 2025 | 53.08M |
| March 31, 2025 | 43.31M |
| December 31, 2024 | -162.80M |
| September 30, 2024 | -142.50M |
| June 30, 2024 | -146.15M |
| March 31, 2024 | -137.18M |
| December 31, 2023 | -126.97M |
| September 30, 2023 | -122.77M |
| June 30, 2023 | -113.01M |
| March 31, 2023 | -105.03M |
| Date | Value |
|---|---|
| December 31, 2022 | -71.30M |
| September 30, 2022 | -69.23M |
| June 30, 2022 | -59.04M |
| March 31, 2022 | -54.03M |
| December 31, 2021 | -63.17M |
| September 30, 2021 | -51.50M |
| June 30, 2021 | -47.80M |
| March 31, 2021 | -39.61M |
| December 31, 2020 | -37.19M |
| September 30, 2020 | -34.65M |
| June 30, 2020 | -26.80M |
| March 31, 2020 | -22.05M |
| December 31, 2019 | -16.27M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Incyte Corp. | 1.890B |
| Nurix Therapeutics, Inc. | -304.53M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.42M |
| Cash from Investing (Quarterly) | -0.155M |
| Cash from Financing (Quarterly) | -3.315M |
| Free Cash Flow Per Share (Quarterly) | -1.039 |
| Free Cash Flow to Equity (Quarterly) | -19.99M |
| Free Cash Flow to Firm (Quarterly) | -20.58M |
| Free Cash Flow Yield | -16.39% |